 | • レポートコード：QY2112C00594 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はネパフェナクの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ネパフェナクの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（98％以下、98％〜99％、99％以上）、用途別市場規模（目薬、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・ネパフェナクの世界市場概要 ・メーカー別の競争状況、市場シェア ・ネパフェナクの種類別市場規模：98％以下、98％〜99％、99％以上 ・ネパフェナクの用途別市場規模：目薬、その他 ・北米のネパフェナク市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのネパフェナク市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのネパフェナク市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のネパフェナク市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのネパフェナク市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Targetmol、Merck、Cayman Chemical、ApexBio Technology、Biorbyt Ltd、GLR Innovations、A&A Life Science Inc、TCI、Novachemistry、Santa Cruz Biotechnology, Inc.、Toronto Research Chemicals、Acanthus Research Inc.、Combi-Blocks、MedChemExpress、BOC Sciences、Jinan Arey Pharmaceutical Co. LTD、Shanghai Aladdin Biochemical Technology Co., LTD、Chengdu McCash Chemical Co., LTD、Jiangsu Aikang Biomedical Research and Development Co. LTD、Macklin Inc ・ネパフェナクのバリューチェーン・販売チャネル分析 ・ネパフェナクの世界市場動向 |
Nepafenac is a monocarboxylic acid amide that is amfenac in which the carboxylic acid group has been converted into the corresponding carboxamide. It is a prodrug for amfenac, used in eye drops to treat pain and inflammation following cataract surgery. It has a role as a prodrug, a cyclooxygenase 2 inhibitor, a cyclooxygenase 1 inhibitor, a non-steroidal anti-inflammatory drug and a non-narcotic analgesic.
Compared with traditional NSAIDs, the chemical structure of neparfenamide is conducive to the rapid penetration of the drug into the cornea and distribution of its target, thus helping to reduce the accumulation of drugs on the cornea surface, reduce the occurrence of ocular surface complications, with strong penetration, strong targeting effect, small toxic side effects and other advantages.Therefore, the future market prospect of neparfenamide is good.
Market Analysis and Insights: Global Nepafenac Market
The global Nepafenac market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
Global Nepafenac Scope and Segment
Nepafenac market is segmented by Purity, and by Application. Players, stakeholders, and other participants in the global Nepafenac market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Purity and by Application for the period 2016-2027.
Segment by Purity
Less than 98%
98% to 99%
More than 99%
Segment by Application
Eye Drops
Others
By Company
Targetmol
Merck
Cayman Chemical
ApexBio Technology
Biorbyt Ltd
GLR Innovations
A&A Life Science Inc
TCI
Novachemistry
Santa Cruz Biotechnology, Inc.
Toronto Research Chemicals
Acanthus Research Inc.
Combi-Blocks
MedChemExpress
BOC Sciences
Jinan Arey Pharmaceutical Co. LTD
Shanghai Aladdin Biochemical Technology Co., LTD
Chengdu McCash Chemical Co., LTD
Jiangsu Aikang Biomedical Research and Development Co. LTD
Macklin Inc
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Nepafenac Product Introduction
1.2 Market by Purity
1.2.1 Global Nepafenac Market Size Growth Rate by Purity
1.2.2 Less than 98%
1.2.3 98% to 99%
1.2.4 More than 99%
1.3 Market by Application
1.3.1 Global Nepafenac Market Size Growth Rate by Application
1.3.2 Eye Drops
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Nepafenac Production
2.1 Global Nepafenac Production Capacity (2016-2027)
2.2 Global Nepafenac Production by Region: 2016 VS 2021 VS 2027
2.3 Global Nepafenac Production by Region
2.3.1 Global Nepafenac Historic Production by Region (2016-2021)
2.3.2 Global Nepafenac Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Nepafenac Sales in Volume & Value Estimates and Forecasts
3.1 Global Nepafenac Sales Estimates and Forecasts 2016-2027
3.2 Global Nepafenac Revenue Estimates and Forecasts 2016-2027
3.3 Global Nepafenac Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Nepafenac Regions by Sales
3.4.1 Global Top Nepafenac Regions by Sales (2016-2021)
3.4.2 Global Top Nepafenac Regions by Sales (2022-2027)
3.5 Global Top Nepafenac Regions by Revenue
3.5.1 Global Top Nepafenac Regions by Revenue (2016-2021)
3.5.2 Global Top Nepafenac Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Nepafenac Production Capacity by Manufacturers
4.2 Global Nepafenac Sales by Manufacturers
4.2.1 Global Top Nepafenac Manufacturers by Sales (2016-2021)
4.2.2 Global Top Nepafenac Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Nepafenac Sales in 2020
4.3 Global Nepafenac Revenue by Manufacturers
4.3.1 Global Top Nepafenac Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Nepafenac Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Nepafenac Revenue in 2020
4.4 Global Nepafenac Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Nepafenac Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Nepafenac Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Nepafenac Sales by Purity
5.1.1 Global Nepafenac Historical Sales by Purity (2016-2021)
5.1.2 Global Nepafenac Forecasted Sales by Purity (2022-2027)
5.1.3 Global Nepafenac Sales Market Share by Purity (2016-2027)
5.2 Global Nepafenac Revenue by Purity
5.2.1 Global Nepafenac Historical Revenue by Purity (2016-2021)
5.2.2 Global Nepafenac Forecasted Revenue by Purity (2022-2027)
5.2.3 Global Nepafenac Revenue Market Share by Purity (2016-2027)
5.3 Global Nepafenac Price by Purity
5.3.1 Global Nepafenac Price by Purity (2016-2021)
5.3.2 Global Nepafenac Price Forecast by Purity (2022-2027)
6 Market Size by Application
6.1 Global Nepafenac Sales by Application
6.1.1 Global Nepafenac Historical Sales by Application (2016-2021)
6.1.2 Global Nepafenac Forecasted Sales by Application (2022-2027)
6.1.3 Global Nepafenac Sales Market Share by Application (2016-2027)
6.2 Global Nepafenac Revenue by Application
6.2.1 Global Nepafenac Historical Revenue by Application (2016-2021)
6.2.2 Global Nepafenac Forecasted Revenue by Application (2022-2027)
6.2.3 Global Nepafenac Revenue Market Share by Application (2016-2027)
6.3 Global Nepafenac Price by Application
6.3.1 Global Nepafenac Price by Application (2016-2021)
6.3.2 Global Nepafenac Price Forecast by Application (2022-2027)
7 North America
7.1 North America Nepafenac Market Size by Purity
7.1.1 North America Nepafenac Sales by Purity (2016-2027)
7.1.2 North America Nepafenac Revenue by Purity (2016-2027)
7.2 North America Nepafenac Market Size by Application
7.2.1 North America Nepafenac Sales by Application (2016-2027)
7.2.2 North America Nepafenac Revenue by Application (2016-2027)
7.3 North America Nepafenac Sales by Country
7.3.1 North America Nepafenac Sales by Country (2016-2027)
7.3.2 North America Nepafenac Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Nepafenac Market Size by Purity
8.1.1 Europe Nepafenac Sales by Purity (2016-2027)
8.1.2 Europe Nepafenac Revenue by Purity (2016-2027)
8.2 Europe Nepafenac Market Size by Application
8.2.1 Europe Nepafenac Sales by Application (2016-2027)
8.2.2 Europe Nepafenac Revenue by Application (2016-2027)
8.3 Europe Nepafenac Sales by Country
8.3.1 Europe Nepafenac Sales by Country (2016-2027)
8.3.2 Europe Nepafenac Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Nepafenac Market Size by Purity
9.1.1 Asia Pacific Nepafenac Sales by Purity (2016-2027)
9.1.2 Asia Pacific Nepafenac Revenue by Purity (2016-2027)
9.2 Asia Pacific Nepafenac Market Size by Application
9.2.1 Asia Pacific Nepafenac Sales by Application (2016-2027)
9.2.2 Asia Pacific Nepafenac Revenue by Application (2016-2027)
9.3 Asia Pacific Nepafenac Sales by Region
9.3.1 Asia Pacific Nepafenac Sales by Region (2016-2027)
9.3.2 Asia Pacific Nepafenac Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Nepafenac Market Size by Purity
10.1.1 Latin America Nepafenac Sales by Purity (2016-2027)
10.1.2 Latin America Nepafenac Revenue by Purity (2016-2027)
10.2 Latin America Nepafenac Market Size by Application
10.2.1 Latin America Nepafenac Sales by Application (2016-2027)
10.2.2 Latin America Nepafenac Revenue by Application (2016-2027)
10.3 Latin America Nepafenac Sales by Country
10.3.1 Latin America Nepafenac Sales by Country (2016-2027)
10.3.2 Latin America Nepafenac Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Nepafenac Market Size by Purity
11.1.1 Middle East and Africa Nepafenac Sales by Purity (2016-2027)
11.1.2 Middle East and Africa Nepafenac Revenue by Purity (2016-2027)
11.2 Middle East and Africa Nepafenac Market Size by Application
11.2.1 Middle East and Africa Nepafenac Sales by Application (2016-2027)
11.2.2 Middle East and Africa Nepafenac Revenue by Application (2016-2027)
11.3 Middle East and Africa Nepafenac Sales by Country
11.3.1 Middle East and Africa Nepafenac Sales by Country (2016-2027)
11.3.2 Middle East and Africa Nepafenac Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Targetmol
12.1.1 Targetmol Corporation Information
12.1.2 Targetmol Overview
12.1.3 Targetmol Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Targetmol Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Targetmol Recent Developments
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Overview
12.2.3 Merck Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Merck Recent Developments
12.3 Cayman Chemical
12.3.1 Cayman Chemical Corporation Information
12.3.2 Cayman Chemical Overview
12.3.3 Cayman Chemical Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Cayman Chemical Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Cayman Chemical Recent Developments
12.4 ApexBio Technology
12.4.1 ApexBio Technology Corporation Information
12.4.2 ApexBio Technology Overview
12.4.3 ApexBio Technology Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 ApexBio Technology Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 ApexBio Technology Recent Developments
12.5 Biorbyt Ltd
12.5.1 Biorbyt Ltd Corporation Information
12.5.2 Biorbyt Ltd Overview
12.5.3 Biorbyt Ltd Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.5.4 Biorbyt Ltd Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Biorbyt Ltd Recent Developments
12.6 GLR Innovations
12.6.1 GLR Innovations Corporation Information
12.6.2 GLR Innovations Overview
12.6.3 GLR Innovations Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.6.4 GLR Innovations Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 GLR Innovations Recent Developments
12.7 A&A Life Science Inc
12.7.1 A&A Life Science Inc Corporation Information
12.7.2 A&A Life Science Inc Overview
12.7.3 A&A Life Science Inc Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.7.4 A&A Life Science Inc Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 A&A Life Science Inc Recent Developments
12.8 TCI
12.8.1 TCI Corporation Information
12.8.2 TCI Overview
12.8.3 TCI Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.8.4 TCI Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 TCI Recent Developments
12.9 Novachemistry
12.9.1 Novachemistry Corporation Information
12.9.2 Novachemistry Overview
12.9.3 Novachemistry Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.9.4 Novachemistry Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Novachemistry Recent Developments
12.10 Santa Cruz Biotechnology, Inc.
12.10.1 Santa Cruz Biotechnology, Inc. Corporation Information
12.10.2 Santa Cruz Biotechnology, Inc. Overview
12.10.3 Santa Cruz Biotechnology, Inc. Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.10.4 Santa Cruz Biotechnology, Inc. Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Santa Cruz Biotechnology, Inc. Recent Developments
12.11 Toronto Research Chemicals
12.11.1 Toronto Research Chemicals Corporation Information
12.11.2 Toronto Research Chemicals Overview
12.11.3 Toronto Research Chemicals Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.11.4 Toronto Research Chemicals Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Toronto Research Chemicals Recent Developments
12.12 Acanthus Research Inc.
12.12.1 Acanthus Research Inc. Corporation Information
12.12.2 Acanthus Research Inc. Overview
12.12.3 Acanthus Research Inc. Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.12.4 Acanthus Research Inc. Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Acanthus Research Inc. Recent Developments
12.13 Combi-Blocks
12.13.1 Combi-Blocks Corporation Information
12.13.2 Combi-Blocks Overview
12.13.3 Combi-Blocks Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.13.4 Combi-Blocks Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Combi-Blocks Recent Developments
12.14 MedChemExpress
12.14.1 MedChemExpress Corporation Information
12.14.2 MedChemExpress Overview
12.14.3 MedChemExpress Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.14.4 MedChemExpress Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 MedChemExpress Recent Developments
12.15 BOC Sciences
12.15.1 BOC Sciences Corporation Information
12.15.2 BOC Sciences Overview
12.15.3 BOC Sciences Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.15.4 BOC Sciences Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 BOC Sciences Recent Developments
12.16 Jinan Arey Pharmaceutical Co. LTD
12.16.1 Jinan Arey Pharmaceutical Co. LTD Corporation Information
12.16.2 Jinan Arey Pharmaceutical Co. LTD Overview
12.16.3 Jinan Arey Pharmaceutical Co. LTD Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.16.4 Jinan Arey Pharmaceutical Co. LTD Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Jinan Arey Pharmaceutical Co. LTD Recent Developments
12.17 Shanghai Aladdin Biochemical Technology Co., LTD
12.17.1 Shanghai Aladdin Biochemical Technology Co., LTD Corporation Information
12.17.2 Shanghai Aladdin Biochemical Technology Co., LTD Overview
12.17.3 Shanghai Aladdin Biochemical Technology Co., LTD Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.17.4 Shanghai Aladdin Biochemical Technology Co., LTD Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Shanghai Aladdin Biochemical Technology Co., LTD Recent Developments
12.18 Chengdu McCash Chemical Co., LTD
12.18.1 Chengdu McCash Chemical Co., LTD Corporation Information
12.18.2 Chengdu McCash Chemical Co., LTD Overview
12.18.3 Chengdu McCash Chemical Co., LTD Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.18.4 Chengdu McCash Chemical Co., LTD Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Chengdu McCash Chemical Co., LTD Recent Developments
12.19 Jiangsu Aikang Biomedical Research and Development Co. LTD
12.19.1 Jiangsu Aikang Biomedical Research and Development Co. LTD Corporation Information
12.19.2 Jiangsu Aikang Biomedical Research and Development Co. LTD Overview
12.19.3 Jiangsu Aikang Biomedical Research and Development Co. LTD Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.19.4 Jiangsu Aikang Biomedical Research and Development Co. LTD Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 Jiangsu Aikang Biomedical Research and Development Co. LTD Recent Developments
12.20 Macklin Inc
12.20.1 Macklin Inc Corporation Information
12.20.2 Macklin Inc Overview
12.20.3 Macklin Inc Nepafenac Sales, Price, Revenue and Gross Margin (2016-2021)
12.20.4 Macklin Inc Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 Macklin Inc Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Nepafenac Industry Chain Analysis
13.2 Nepafenac Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Nepafenac Production Mode & Process
13.4 Nepafenac Sales and Marketing
13.4.1 Nepafenac Sales Channels
13.4.2 Nepafenac Distributors
13.5 Nepafenac Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Nepafenac Industry Trends
14.2 Nepafenac Market Drivers
14.3 Nepafenac Market Challenges
14.4 Nepafenac Market Restraints
15 Key Finding in The Global Nepafenac Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Nepafenac Market Size Growth Rate by Purity, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Less than 98%
Table 3. Major Manufacturers of 98% to 99%
Table 4. Major Manufacturers of More than 99%
Table 5. Global Nepafenac Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 6. Global Nepafenac Production by Region: 2016 VS 2021 VS 2027 (Kg)
Table 7. Global Nepafenac Production by Region (2016-2021) & (Kg)
Table 8. Global Nepafenac Production Market Share by Region (2016-2021)
Table 9. Global Nepafenac Production by Region (2022-2027) & (Kg)
Table 10. Global Nepafenac Production Market Share by Region (2022-2027)
Table 11. Global Nepafenac Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 12. Global Nepafenac Sales by Region (2016-2021) & (Kg)
Table 13. Global Nepafenac Sales Market Share by Region (2016-2021)
Table 14. Global Nepafenac Sales by Region (2022-2027) & (Kg)
Table 15. Global Nepafenac Sales Market Share by Region (2022-2027)
Table 16. Global Nepafenac Revenue by Region (2016-2021) & (US$ Million)
Table 17. Global Nepafenac Revenue Market Share by Region (2016-2021)
Table 18. Global Nepafenac Revenue by Region (2022-2027) & (US$ Million)
Table 19. Global Nepafenac Revenue Market Share by Region (2022-2027)
Table 20. Global Nepafenac Production Capacity by Manufacturers (2016-2021) & (Kg)
Table 21. Global Nepafenac Capacity Market Share by Manufacturers (2016-2021)
Table 22. Global Nepafenac Production by Manufacturers (2016-2021) & (Kg)
Table 23. Global Nepafenac Production Market Share by Manufacturers (2016-2021)
Table 24. Global Nepafenac Sales by Manufacturers (2016-2021) & (Kg)
Table 25. Global Nepafenac Sales Share by Manufacturers (2016-2021)
Table 26. Global Nepafenac Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 27. Global Nepafenac Revenue Share by Manufacturers (2016-2021)
Table 28. Nepafenac Price by Manufacturers 2016-2021 (US$/g)
Table 29. Global Nepafenac Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Nepafenac by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nepafenac as of 2020)
Table 31. Nepafenac Manufacturing Base Distribution and Headquarters
Table 32. Manufacturers Nepafenac Product Offered
Table 33. Date of Manufacturers Enter into Nepafenac Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Nepafenac Sales by Purity (2016-2021) & (Kg)
Table 36. Global Nepafenac Sales by Purity (2022-2027) & (Kg)
Table 37. Global Nepafenac Sales Share by Purity (2016-2021)
Table 38. Global Nepafenac Sales Share by Purity (2022-2027)
Table 39. Global Nepafenac Revenue by Purity (2016-2021) & (US$ Million)
Table 40. Global Nepafenac Revenue by Purity (2022-2027) & (US$ Million)
Table 41. Global Nepafenac Revenue Share by Purity (2016-2021)
Table 42. Global Nepafenac Revenue Share by Purity (2022-2027)
Table 43. Nepafenac Price by Purity (2016-2021) & (US$/g)
Table 44. Global Nepafenac Price Forecast by Purity (2022-2027) & (US$/g)
Table 45. Global Nepafenac Sales by Application (2016-2021) & (Kg)
Table 46. Global Nepafenac Sales by Application (2022-2027) & (Kg)
Table 47. Global Nepafenac Sales Share by Application (2016-2021)
Table 48. Global Nepafenac Sales Share by Application (2022-2027)
Table 49. Global Nepafenac Revenue by Application (2016-2021) & (US$ Million)
Table 50. Global Nepafenac Revenue by Application (2022-2027) & (US$ Million)
Table 51. Global Nepafenac Revenue Share by Application (2016-2021)
Table 52. Global Nepafenac Revenue Share by Application (2022-2027)
Table 53. Nepafenac Price by Application (2016-2021) & (US$/g)
Table 54. Global Nepafenac Price Forecast by Application (2022-2027) & (US$/g)
Table 55. North America Nepafenac Sales by Purity (2016-2021) & (Kg)
Table 56. North America Nepafenac Sales by Purity (2022-2027) & (Kg)
Table 57. North America Nepafenac Revenue by Purity (2016-2021) & (US$ Million)
Table 58. North America Nepafenac Revenue by Purity (2022-2027) & (US$ Million)
Table 59. North America Nepafenac Sales by Application (2016-2021) & (Kg)
Table 60. North America Nepafenac Sales by Application (2022-2027) & (Kg)
Table 61. North America Nepafenac Revenue by Application (2016-2021) & (US$ Million)
Table 62. North America Nepafenac Revenue by Application (2022-2027) & (US$ Million)
Table 63. North America Nepafenac Sales by Country (2016-2021) & (Kg)
Table 64. North America Nepafenac Sales by Country (2022-2027) & (Kg)
Table 65. North America Nepafenac Revenue by Country (2016-2021) & (US$ Million)
Table 66. North America Nepafenac Revenue by Country (2022-2027) & (US$ Million)
Table 67. Europe Nepafenac Sales by Purity (2016-2021) & (Kg)
Table 68. Europe Nepafenac Sales by Purity (2022-2027) & (Kg)
Table 69. Europe Nepafenac Revenue by Purity (2016-2021) & (US$ Million)
Table 70. Europe Nepafenac Revenue by Purity (2022-2027) & (US$ Million)
Table 71. Europe Nepafenac Sales by Application (2016-2021) & (Kg)
Table 72. Europe Nepafenac Sales by Application (2022-2027) & (Kg)
Table 73. Europe Nepafenac Revenue by Application (2016-2021) & (US$ Million)
Table 74. Europe Nepafenac Revenue by Application (2022-2027) & (US$ Million)
Table 75. Europe Nepafenac Sales by Country (2016-2021) & (Kg)
Table 76. Europe Nepafenac Sales by Country (2022-2027) & (Kg)
Table 77. Europe Nepafenac Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Nepafenac Revenue by Country (2022-2027) & (US$ Million)
Table 79. Asia Pacific Nepafenac Sales by Purity (2016-2021) & (Kg)
Table 80. Asia Pacific Nepafenac Sales by Purity (2022-2027) & (Kg)
Table 81. Asia Pacific Nepafenac Revenue by Purity (2016-2021) & (US$ Million)
Table 82. Asia Pacific Nepafenac Revenue by Purity (2022-2027) & (US$ Million)
Table 83. Asia Pacific Nepafenac Sales by Application (2016-2021) & (Kg)
Table 84. Asia Pacific Nepafenac Sales by Application (2022-2027) & (Kg)
Table 85. Asia Pacific Nepafenac Revenue by Application (2016-2021) & (US$ Million)
Table 86. Asia Pacific Nepafenac Revenue by Application (2022-2027) & (US$ Million)
Table 87. Asia Pacific Nepafenac Sales by Region (2016-2021) & (Kg)
Table 88. Asia Pacific Nepafenac Sales by Region (2022-2027) & (Kg)
Table 89. Asia Pacific Nepafenac Revenue by Region (2016-2021) & (US$ Million)
Table 90. Asia Pacific Nepafenac Revenue by Region (2022-2027) & (US$ Million)
Table 91. Latin America Nepafenac Sales by Purity (2016-2021) & (Kg)
Table 92. Latin America Nepafenac Sales by Purity (2022-2027) & (Kg)
Table 93. Latin America Nepafenac Revenue by Purity (2016-2021) & (US$ Million)
Table 94. Latin America Nepafenac Revenue by Purity (2022-2027) & (US$ Million)
Table 95. Latin America Nepafenac Sales by Application (2016-2021) & (Kg)
Table 96. Latin America Nepafenac Sales by Application (2022-2027) & (Kg)
Table 97. Latin America Nepafenac Revenue by Application (2016-2021) & (US$ Million)
Table 98. Latin America Nepafenac Revenue by Application (2022-2027) & (US$ Million)
Table 99. Latin America Nepafenac Sales by Country (2016-2021) & (Kg)
Table 100. Latin America Nepafenac Sales by Country (2022-2027) & (Kg)
Table 101. Latin America Nepafenac Revenue by Country (2016-2021) & (US$ Million)
Table 102. Latin America Nepafenac Revenue by Country (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Nepafenac Sales by Purity (2016-2021) & (Kg)
Table 104. Middle East and Africa Nepafenac Sales by Purity (2022-2027) & (Kg)
Table 105. Middle East and Africa Nepafenac Revenue by Purity (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Nepafenac Revenue by Purity (2022-2027) & (US$ Million)
Table 107. Middle East and Africa Nepafenac Sales by Application (2016-2021) & (Kg)
Table 108. Middle East and Africa Nepafenac Sales by Application (2022-2027) & (Kg)
Table 109. Middle East and Africa Nepafenac Revenue by Application (2016-2021) & (US$ Million)
Table 110. Middle East and Africa Nepafenac Revenue by Application (2022-2027) & (US$ Million)
Table 111. Middle East and Africa Nepafenac Sales by Country (2016-2021) & (Kg)
Table 112. Middle East and Africa Nepafenac Sales by Country (2022-2027) & (Kg)
Table 113. Middle East and Africa Nepafenac Revenue by Country (2016-2021) & (US$ Million)
Table 114. Middle East and Africa Nepafenac Revenue by Country (2022-2027) & (US$ Million)
Table 115. Targetmol Corporation Information
Table 116. Targetmol Description and Major Businesses
Table 117. Targetmol Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 118. Targetmol Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Targetmol Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Major Businesses
Table 122. Merck Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 123. Merck Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Merck Recent Development
Table 125. Cayman Chemical Corporation Information
Table 126. Cayman Chemical Description and Major Businesses
Table 127. Cayman Chemical Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 128. Cayman Chemical Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Cayman Chemical Recent Development
Table 130. ApexBio Technology Corporation Information
Table 131. ApexBio Technology Description and Major Businesses
Table 132. ApexBio Technology Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 133. ApexBio Technology Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. ApexBio Technology Recent Development
Table 135. Biorbyt Ltd Corporation Information
Table 136. Biorbyt Ltd Description and Major Businesses
Table 137. Biorbyt Ltd Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 138. Biorbyt Ltd Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Biorbyt Ltd Recent Development
Table 140. GLR Innovations Corporation Information
Table 141. GLR Innovations Description and Major Businesses
Table 142. GLR Innovations Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 143. GLR Innovations Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. GLR Innovations Recent Development
Table 145. A&A Life Science Inc Corporation Information
Table 146. A&A Life Science Inc Description and Major Businesses
Table 147. A&A Life Science Inc Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 148. A&A Life Science Inc Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. A&A Life Science Inc Recent Development
Table 150. TCI Corporation Information
Table 151. TCI Description and Major Businesses
Table 152. TCI Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 153. TCI Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. TCI Recent Development
Table 155. Novachemistry Corporation Information
Table 156. Novachemistry Description and Major Businesses
Table 157. Novachemistry Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 158. Novachemistry Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Novachemistry Recent Development
Table 160. Santa Cruz Biotechnology, Inc. Corporation Information
Table 161. Santa Cruz Biotechnology, Inc. Description and Major Businesses
Table 162. Santa Cruz Biotechnology, Inc. Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 163. Santa Cruz Biotechnology, Inc. Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Santa Cruz Biotechnology, Inc. Recent Development
Table 165. Toronto Research Chemicals Corporation Information
Table 166. Toronto Research Chemicals Description and Major Businesses
Table 167. Toronto Research Chemicals Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 168. Toronto Research Chemicals Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Toronto Research Chemicals Recent Development
Table 170. Acanthus Research Inc. Corporation Information
Table 171. Acanthus Research Inc. Description and Major Businesses
Table 172. Acanthus Research Inc. Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 173. Acanthus Research Inc. Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Acanthus Research Inc. Recent Development
Table 175. Combi-Blocks Corporation Information
Table 176. Combi-Blocks Description and Major Businesses
Table 177. Combi-Blocks Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 178. Combi-Blocks Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Combi-Blocks Recent Development
Table 180. MedChemExpress Corporation Information
Table 181. MedChemExpress Description and Major Businesses
Table 182. MedChemExpress Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 183. MedChemExpress Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. MedChemExpress Recent Development
Table 185. BOC Sciences Corporation Information
Table 186. BOC Sciences Description and Major Businesses
Table 187. BOC Sciences Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 188. BOC Sciences Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. BOC Sciences Recent Development
Table 190. Jinan Arey Pharmaceutical Co. LTD Corporation Information
Table 191. Jinan Arey Pharmaceutical Co. LTD Description and Major Businesses
Table 192. Jinan Arey Pharmaceutical Co. LTD Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 193. Jinan Arey Pharmaceutical Co. LTD Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Jinan Arey Pharmaceutical Co. LTD Recent Development
Table 195. Shanghai Aladdin Biochemical Technology Co., LTD Corporation Information
Table 196. Shanghai Aladdin Biochemical Technology Co., LTD Description and Major Businesses
Table 197. Shanghai Aladdin Biochemical Technology Co., LTD Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 198. Shanghai Aladdin Biochemical Technology Co., LTD Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Shanghai Aladdin Biochemical Technology Co., LTD Recent Development
Table 200. Chengdu McCash Chemical Co., LTD Corporation Information
Table 201. Chengdu McCash Chemical Co., LTD Description and Major Businesses
Table 202. Chengdu McCash Chemical Co., LTD Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 203. Chengdu McCash Chemical Co., LTD Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Chengdu McCash Chemical Co., LTD Recent Development
Table 205. Jiangsu Aikang Biomedical Research and Development Co. LTD Corporation Information
Table 206. Jiangsu Aikang Biomedical Research and Development Co. LTD Description and Major Businesses
Table 207. Jiangsu Aikang Biomedical Research and Development Co. LTD Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 208. Jiangsu Aikang Biomedical Research and Development Co. LTD Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 209. Jiangsu Aikang Biomedical Research and Development Co. LTD Recent Development
Table 210. Macklin Inc Corporation Information
Table 211. Macklin Inc Description and Major Businesses
Table 212. Macklin Inc Nepafenac Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 213. Macklin Inc Nepafenac Product Model Numbers, Pictures, Descriptions and Specifications
Table 214. Macklin Inc Recent Development
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Nepafenac Distributors List
Table 218. Nepafenac Customers List
Table 219. Nepafenac Market Trends
Table 220. Nepafenac Market Drivers
Table 221. Nepafenac Market Challenges
Table 222. Nepafenac Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Nepafenac Product Picture
Figure 2. Global Nepafenac Market Share by Purity in 2020 & 2027
Figure 3. Less than 98% Product Picture
Figure 4. 98% to 99% Product Picture
Figure 5. More than 99% Product Picture
Figure 6. Global Nepafenac Market Share by Application in 2020 & 2027
Figure 7. Eye Drops
Figure 8. Others
Figure 9. Nepafenac Report Years Considered
Figure 10. Global Nepafenac Capacity, Production and Utilization (2016-2027) & (Kg)
Figure 11. Global Nepafenac Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 12. Global Nepafenac Production Market Share by Region (2016-2021)
Figure 13. Global Nepafenac Production Market Share by Region (2022-2027)
Figure 14. Nepafenac Production Growth Rate in North America (2016-2027) & (Kg)
Figure 15. Nepafenac Production Growth Rate in Europe (2016-2027) & (Kg)
Figure 16. Nepafenac Production Growth Rate in China (2016-2027) & (Kg)
Figure 17. Nepafenac Production Growth Rate in Japan (2016-2027) & (Kg)
Figure 18. Global Nepafenac Sales 2016-2027 (Kg)
Figure 19. Global Nepafenac Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Nepafenac Revenue 2016-2027 (US$ Million)
Figure 21. Global Nepafenac Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 22. Global Nepafenac Sales Market Share by Region (2016-2021)
Figure 23. Global Nepafenac Sales Market Share by Region (2022-2027)
Figure 24. North America Nepafenac Sales YoY (2016-2027) & (Kg)
Figure 25. North America Nepafenac Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Europe Nepafenac Sales YoY (2016-2027) & (Kg)
Figure 27. Europe Nepafenac Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Asia-Pacific Nepafenac Sales YoY (2016-2027) & (Kg)
Figure 29. Asia-Pacific Nepafenac Revenue YoY (2016-2027) & (US$ Million)
Figure 30. Latin America Nepafenac Sales YoY (2016-2027) & (Kg)
Figure 31. Latin America Nepafenac Revenue YoY (2016-2027) & (US$ Million)
Figure 32. Middle East & Africa Nepafenac Sales YoY (2016-2027) & (Kg)
Figure 33. Middle East & Africa Nepafenac Revenue YoY (2016-2027) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Nepafenac Sales in 2020
Figure 35. The Top 10 and Top 5 Players Market Share by Nepafenac Revenue in 2020
Figure 36. Nepafenac Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 37. Global Nepafenac Sales Market Share by Purity (2016-2027)
Figure 38. Global Nepafenac Revenue Market Share by Purity (2016-2027)
Figure 39. Global Nepafenac Sales Market Share by Application (2016-2027)
Figure 40. Global Nepafenac Revenue Market Share by Application (2016-2027)
Figure 41. North America Nepafenac Sales Market Share by Purity (2016-2027)
Figure 42. North America Nepafenac Revenue Market Share by Purity (2016-2027)
Figure 43. North America Nepafenac Sales Market Share by Application (2016-2027)
Figure 44. North America Nepafenac Revenue Market Share by Application (2016-2027)
Figure 45. North America Nepafenac Sales Share by Country (2016-2027)
Figure 46. North America Nepafenac Revenue Share by Country (2016-2027)
Figure 47. United States Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 48. Canada Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 49. Europe Nepafenac Sales Market Share by Purity (2016-2027)
Figure 50. Europe Nepafenac Revenue Market Share by Purity (2016-2027)
Figure 51. Europe Nepafenac Sales Market Share by Application (2016-2027)
Figure 52. Europe Nepafenac Revenue Market Share by Application (2016-2027)
Figure 53. Europe Nepafenac Sales Share by Country (2016-2027)
Figure 54. Europe Nepafenac Revenue Share by Country (2016-2027)
Figure 55. Germany Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 56. France Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 57. U.K. Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 58. Italy Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 59. Russia Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 60. Asia Pacific Nepafenac Sales Market Share by Purity (2016-2027)
Figure 61. Asia Pacific Nepafenac Revenue Market Share by Purity (2016-2027)
Figure 62. Asia Pacific Nepafenac Sales Market Share by Application (2016-2027)
Figure 63. Asia Pacific Nepafenac Revenue Market Share by Application (2016-2027)
Figure 64. Asia Pacific Nepafenac Sales Share by Region (2016-2027)
Figure 65. Asia Pacific Nepafenac Revenue Share by Region (2016-2027)
Figure 66. China Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 67. Japan Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 68. South Korea Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 69. India Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 70. Australia Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 71. China Taiwan Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 72. Indonesia Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 73. Thailand Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 74. Malaysia Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 75. Latin America Nepafenac Sales Market Share by Purity (2016-2027)
Figure 76. Latin America Nepafenac Revenue Market Share by Purity (2016-2027)
Figure 77. Latin America Nepafenac Sales Market Share by Application (2016-2027)
Figure 78. Latin America Nepafenac Revenue Market Share by Application (2016-2027)
Figure 79. Latin America Nepafenac Sales Share by Country (2016-2027)
Figure 80. Latin America Nepafenac Revenue Share by Country (2016-2027)
Figure 81. Mexico Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 82. Brazil Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 83. Argentina Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 84. Colombia Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 85. Middle East and Africa Nepafenac Sales Market Share by Purity (2016-2027)
Figure 86. Middle East and Africa Nepafenac Revenue Market Share by Purity (2016-2027)
Figure 87. Middle East and Africa Nepafenac Sales Market Share by Application (2016-2027)
Figure 88. Middle East and Africa Nepafenac Revenue Market Share by Application (2016-2027)
Figure 89. Middle East and Africa Nepafenac Sales Share by Country (2016-2027)
Figure 90. Middle East and Africa Nepafenac Revenue Share by Country (2016-2027)
Figure 91. Turkey Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 92. Saudi Arabia Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 93. UAE Nepafenac Revenue (2016-2027) & (US$ Million)
Figure 94. Nepafenac Value Chain
Figure 95. Nepafenac Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
ヒアルロン酸点眼液のグローバル市場インサイト・予測（～2027年） Hyaluronic Acid Eye Drops are also known as 'artificial tears'. They are used to relieve eye dryness and soreness. They moisten, soothe and lubricate the surface of your eye, making it feel more comfortable. Market Analysis and Insights: Global Hyaluronic Acid Eye Drops Market The global Hyaluronic …- 太陽光エネルギーセル用高純度スパッタリングターゲット材料のグローバル市場インサイト・予測（～2027年） Sputtering is the process of forming a thin film when the object is attached to the target substrate by the sputtering and scattering, and the sputtering target is the material for high-speed particle bombardment. In this report, we counted the high purity sputtering target material with 4N (purity≥…
- 半導体用高純度スパッタリングターゲット材料のグローバル市場インサイト・予測（～2027年） Sputtering is the process of forming a thin film when the object is attached to the target substrate by the sputtering and scattering, and the sputtering target is the material for high-speed particle bombardment. In this report, we counted the high purity sputtering target material with 4N (purity≥…
- オクチノキサート（OMC）のグローバル市場インサイト・予測（～2027年） Octinoxate (OMC) is one of the most commonly used sunscreens in the world. It has an excellent UV absorption curve of 280-310 nm, high absorption rate, good safety, minimal toxicity and good solubility to oily raw materials, so it is widely used in sunscreen (cream, milk, liquid) and other skin care…
- イソペンテンのグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Isopentene (CAS 513-35-9) Market The global Isopentene (CAS 513-35-9) market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Isopentene (CAS 513-35-9) Scope and Segment I…